PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26508837-15	2015	CONCLUSION: The data showed that GW0742 has the ability to improve glucose homeostasis in diabetic rats through activation of PPAR-delta.	GW0742	33-39	peroxisome proliferator activated receptor alpha	Rattus norvegicus	126-130	
26508837-0	2015	Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals.	GW0742	28-34	peroxisome proliferator activated receptor alpha	Rattus norvegicus	15-19	
24128860-2	2014	SC cultures obtained from 20-day-old rats were incubated with WY14643 or GW0742-pharmacological activators of PPAR alpha and PPAR beta/delta respectively.	GW0742	73-79	peroxisome proliferator activated receptor alpha	Rattus norvegicus	110-120	
34203800-3	2021	For this purpose, rats were treated with PPARbeta/delta agonist GW0742 and/or antagonist GSK0660 in vivo and hearts were subjected to ex vivo global ischemia followed by reperfusion.	GW0742	64-70	peroxisome proliferator activated receptor alpha	Rattus norvegicus	41-49	
33034416-9	2020	Either PPAR-beta/delta antagonist GSK3787, miR-17-5p inhibitor, or TXNIP CRISPR activation abolished the anti-inflammatory effects of GW0742.	GW0742	134-140	peroxisome proliferator activated receptor alpha	Rattus norvegicus	7-22	
33034416-10	2020	Activation of PPAR-beta/delta by GW0742 activated miR-17-5p expression in PC12 cells and increased cell viability after OGD, which was accompanied by decreased expression of TXNIP and reduced secretion of IL-1beta and TNF-alpha.	GW0742	33-39	peroxisome proliferator activated receptor alpha	Rattus norvegicus	14-23	
34699845-7	2022	The effect of high glucose was inhibited by GW0742, a PPARbeta agonist.	GW0742	44-50	peroxisome proliferator activated receptor alpha	Rattus norvegicus	54-62	
34699845-8	2022	Both GSK0660 (PPARbeta antagonist) and NG-nitro-l-arginine-methyl ester (NOS inhibitor) could reverse the protective effects of GW0742.	GW0742	128-134	peroxisome proliferator activated receptor alpha	Rattus norvegicus	14-22